Regulation of urokinase receptor expression by protein tyrosine phosphatases

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 292, Issue 2, 2007, Pages

  Shetty, Sreerama ^a   Velusamy, Thirunavukkarasu ^a   Idell, Steven ^a   Tang, Hua ^a   Shetty, Praveen Kumar ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Messenger ribonucleic acid binding proteins; Messenger ribonucleic acid stability; Phosphatase

Indexed keywords

MESSENGER RNA; PHOSPHOGLYCERATE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; RIBONUCLEOPROTEIN; UROKINASE; UROKINASE RECEPTOR; VANADATE SODIUM;

ARTICLE; BASAL CELL; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONCENTRATION (PARAMETERS); ENZYME INDUCTION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; MORPHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STABILITY; TIME; UNTRANSLATED REGION;

CELLS, CULTURED; ENZYME INHIBITORS; EPITHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN BINDING; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, CELL SURFACE; RNA STABILITY; RNA, MESSENGER; URINARY PLASMINOGEN ACTIVATOR; VANADATES;

EID: 33847082913     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00121.2006     Document Type: Article

References (43)

1. Abraham E, Gyetko MR, Kuhn K, Arcaroli J, Strassheim D, Park JS, Shetty S, Idell S. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J Immunol 170: 5644-5651, 2003.
2. Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57: 25-40, 2000.
3. Bhat GJ, Gunaje JJ, Idell S. Urokinase-type plasminogen activator induces tyrosine phosphorylation of a 78-kDa protein in H-157 cells. Am J Physiol Lung Cell Mol Physiol 277: L301-L309, 1999.
4. Blasi F, Vassalli JD, Dano K. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol 104: 801-804, 1987.
5. 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 181: 1381-1390, 1995.
6. Carlin SM, Resnik TJ, Tamm M, Roth M. Urokinase signal transduction and its role in cell migration. FASEB J 19: 195-202, 2005.
7. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, cancer. Adv Cancer Res 44: 139-266, 1985.
8. Dumler I, Kopmann A, Wagner K, Mayboroda OA, Jerke U, Dietz R, Haller H, Gulba DC. Urokinase induces activation and formation of Stat4 and Stat1-Stat2 complexes in human vascular smooth muscle cells. J Biol Chem 274: 24059-24065, 1999.
9. Dumler I, Kopmann A, Weis A, Mayboroda OA, Wagner K, Gulba DC, Haller H. Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 19: 290-297, 1999.
10. Dumler I, Petri T, Schleuning WD. Interaction of urokinase-type plasminogen activator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett 322: 37-40, 1993.
11. Ghiso JAA, Alonso DF, Farias EF, Gomez DE, Bal de Kier Joffe E. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur J Biochem 263: 295-304, 1999.
12. Huang S, New L, Pan Z, Han J, Nemerow GR. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38α mitogen-activated protein kinase activity. J Biol Chem 275: 12266-12272, 2000.
13. Lardot CG, Huaux FA, Broeckaert FR, Declerck PJ, Delos M, Fubini B, Lison DF. Role of urokinase in the fibrogenic response of the lung to mineral particles. Am J Respir Crit Care Med 157: 617-628, 1998.
14. Liotta LA, Stetler-Stevenson WG, Steeg PS. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest 9: 543-551, 1991.
15. Lund LR, Ellis V, Ronne E, Pyke C, Dano K. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem J 310: 345-352, 1995.
16. Lund LR, Ronne E, Roldan AL, Behrendt N, Romer J, Blasi F, Dano K. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. J Biol Chem 266: 5177-5181, 1991.
17. Mazar AP, Henkin J, Goldfarb RH. The urokinase plasminogen activator system in cancer: Implications for tumor angiogenesis and metastasis. Angiogenesis 3: 15-32, 2000.
18. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993.
19. Montero L, Nagamine Y. Regulation by p38 Mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion. Cancer Res 59: 5286 -5293, 1999.
20. Montuori N, Mattiello A, Mancini A, Santoli M, Taglialatela P, Caputi M, Rossi G, Ragno P. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor through a post-transcriptional mechanism. FEBS Lett 508: 379-384, 2001.
21. Montuori N, Mattiello A, Mancini A, Taglialatela P, Caputi M, Rossi G, Ragno P. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma. Int J Cancer 105: 353-360, 2003.
22. Montuori N, Salzano S, Rossi G, Ragno P. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor. FEBS Lett 476: 166-170, 2000.
23. Nishiuma T, Sisson TH, Subbotina N, Simon RH. Localization of plasminogen activator activity within normal and injured lungs by in situ zymography. Am J Respir Cell Mol Biol 31: 552-558, 2004.
24. Olman M, Mackman N, Gladson CL, Moser KM, Loskutoff DJ. Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest 96: 1621-1630, 1999.
25. Pepper MS, Matsumoto K, Nakamura T, Orci L, Montesano R. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol Chem 267: 20493-20496, 1992.
26. Plataki M, Koutsopoulos AV, Darivianaki K, Delides G, Siafakas NM, Bouros D. Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 127: 266-274, 2005.
27. Plesner T, Ralfkiaer E, Wittrup M, Johnsen H, Pyke C, Pedersen TL, Hansen NE, Dano K. Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue. Am J Clin Pathol 102: 835-841, 1994.
28. Shetty S, Idell S. Urokinase receptor mRNA stability involves tyrosine phosphorylation in lung epithelial cells. Am J Respir Cell Mol Biol 30: 69-75, 2004.
29. Shetty S, Muniyappa H, Halady PK, Idell S. Regulation of urokinase receptor expression by phosphoglycerate kinase. Am J Respir Cell Mol Biol 31: 100-106, 2004.
30. Shetty S, Kumar A, Johnson A, Idell S. Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor. Antisense Res Dev 5: 307-314, 1995.
31. Shetty S. Regulation of urokinase receptor mRNA stability by hnRNPC in lung epithelial cells. Mol Cell Biochem 272: 107-118, 2005.
32. Shetty S, Idell S. Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro. Mol Cell Biochem 199: 189-200, 1999.
33. Shetty S, Idell S. Urokinase induces expression of its own receptor in Beas2B lung epithelial cells. J Biol Chem 276: 24549-24556, 2001.
34. Shetty S, Kumar A, Idell S. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol Cell Biol 17: 1075-1083, 1997.
35. Shetty S, Kumar A, Johnson A, Pueblitz S, Idell S. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am J Physiol Lung Cell Mol Physiol 268: L972-L982, 1995.
36. Sisson TH, Hattori N, Xu Y, Simon RH. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes. Hum Gene Ther 10: 2315-2323, 1999.
37. Swaisgood CM, French EL, Noga C, Simon RH, Ploplis VA. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am J Pathol 157: 177-187, 2000.
38. Vassalli JD, Pepper MS. Tumour biology. Membrane proteases in focus. Nature 370: 14-15, 1994.
39. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 88: 1067-1072, 1991.
40. Waltz DA, Sailor LZ, Chapman HA. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Clin Invest 91: 1541-1552, 1993.
41. Wang GJ, Collinge M, Blasi F, Pardi R, Bender JR. Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement. Proc Natl Acad Sci USA 95: 6296-6301, 1998.
42. Wang Y, Jones CJ, Dang J, Liang X, Olsen JE, Doe WF. Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells. FEBS Lett 353: 138-142, 1994.
43. Xing RH, Mazar A, Henkin J, Rabbani SA. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428. Cancer Res 57: 3585-3593, 1997.